2022
DOI: 10.1371/journal.pone.0273482
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2 infections in infants in Haiti 2020–2021; evidence from a seroepidemiological cohort

Abstract: Few data are available on frequency of SARS-CoV-2 infection among very young children in low- to middle-income countries (LMIC), with the studies that are available biased towards higher income countries with low reported infection and seroconversion rates. Between February 2019 and March 2021, 388 dried blood spot (DBS) samples were obtained from 257 children less than 30 months of age as part of a prospective observational cohort study of pregnant women and their infants in Haiti; longitudinal samples were a… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 21 publications
(28 reference statements)
0
1
0
Order By: Relevance
“…In this context, serological assays emerged as a powerful tool in the management of this global health issue. Firstly, as an indirect measure of the virus, given that antibodies constitute the host’s response to infection and, in that sense, serology allows determining previous exposures to the virus and the extent of the viral spread by performing epidemiological seroconversion studies [ 6 , 7 , 8 ]. Nonetheless, during SARS-CoV-2 infection, antibody responses are variable and generate controversy in terms of immunity and persistence [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…In this context, serological assays emerged as a powerful tool in the management of this global health issue. Firstly, as an indirect measure of the virus, given that antibodies constitute the host’s response to infection and, in that sense, serology allows determining previous exposures to the virus and the extent of the viral spread by performing epidemiological seroconversion studies [ 6 , 7 , 8 ]. Nonetheless, during SARS-CoV-2 infection, antibody responses are variable and generate controversy in terms of immunity and persistence [ 9 ].…”
Section: Introductionmentioning
confidence: 99%